Koliane Ouk

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

A transcriptomic microglia taxonomy across mouse and human pathologies.

A transcriptomic microglia taxonomy across mouse and human pathologies.

Journal: Nature immunology
Published: November 28, 2025

Rapamycin treatment reduces CD11c+ microglia and increases amyloid plaque load in 5xFAD mice.

Rapamycin treatment reduces CD11c+ microglia and increases amyloid plaque load in 5xFAD mice.

Journal: Experimental neurology
Published: August 03, 2025

Lifelong absence of microglia alters hippocampal glutamatergic networks but not synapse and spine density.

Lifelong absence of microglia alters hippocampal glutamatergic networks but not synapse and spine density.

Journal: EMBO reports
Published: February 27, 2024

Dysfunction of circadian and sleep rhythms in the early stages of Alzheimer's disease.

Dysfunction of circadian and sleep rhythms in the early stages of Alzheimer's disease.

Journal: Acta physiologica (Oxford, England)
Published: October 29, 2022

Mapping brain gene coexpression in daytime transcriptomes unveils diurnal molecular networks and deciphers perturbation gene signatures.

Mapping brain gene coexpression in daytime transcriptomes unveils diurnal molecular networks and deciphers perturbation gene signatures.

Journal: Neuron
Published: May 11, 2022

Analysis of the Circadian Regulation of Cancer Hallmarks by a Cross-Platform Study of Colorectal Cancer Time-Series Data Reveals an Association with Genes Involved in Huntington's Disease.

Analysis of the Circadian Regulation of Cancer Hallmarks by a Cross-Platform Study of Colorectal Cancer Time-Series Data Reveals an Association with Genes Involved in Huntington's Disease.

Journal: Cancers
Published: March 04, 2020

Lentiviral delivery of human erythropoietin attenuates hippocampal atrophy and improves cognition in the R6/2 mouse model of Huntington's disease.

Lentiviral delivery of human erythropoietin attenuates hippocampal atrophy and improves cognition in the R6/2 mouse model of Huntington's disease.

Journal: Neurobiology of disease
Published: March 03, 2020

Abnormal Photic Entrainment to Phase-Delaying Stimuli in the R6/2 Mouse Model of Huntington's Disease, despite Retinal Responsiveness to Light.

Abnormal Photic Entrainment to Phase-Delaying Stimuli in the R6/2 Mouse Model of Huntington's Disease, despite Retinal Responsiveness to Light.

Journal: eNeuro
Published: March 01, 2019

Chronic paroxetine treatment prevents disruption of methamphetamine-sensitive circadian oscillator in a transgenic mouse model of Huntington's disease.

Chronic paroxetine treatment prevents disruption of methamphetamine-sensitive circadian oscillator in a transgenic mouse model of Huntington's disease.

Journal: Neuropharmacology
Published: June 01, 2017

Attenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington's disease.

Attenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington's disease.

Journal: Human molecular genetics
Published: July 25, 2016

Prolonged day length exposure improves circadian deficits and survival in a transgenic mouse model of Huntington's disease.

Prolonged day length exposure improves circadian deficits and survival in a transgenic mouse model of Huntington's disease.

Journal: Neurobiology of sleep and circadian rhythms
Published: July 21, 2016

Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease.

Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease.

Journal: Experimental neurology
Published: May 23, 2016
Showing 1-12 of 12

Last Updated: 09/26/2026